Business Description
Mycenax Biotech Inc
NAICS : 325412
SIC : 2834
ISIN : TW0004726005
Compare
Compare
Traded in other countries / regions
4726.Taiwan IPO Date
2013-12-25Description
Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.52 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.41 | |||||
| Debt-to-EBITDA | -5.51 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 4.47 | |||||
| Beneish M-Score | -3.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -15 | |||||
| 3-Year FCF Growth Rate | -45 | |||||
| 3-Year Book Growth Rate | 8 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.89 | |||||
| 9-Day RSI | 46.98 | |||||
| 14-Day RSI | 46.53 | |||||
| 6-1 Month Momentum % | 59.15 | |||||
| 12-1 Month Momentum % | 56.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.54 | |||||
| Quick Ratio | 1.39 | |||||
| Cash Ratio | 0.75 | |||||
| Days Inventory | 51.06 | |||||
| Days Sales Outstanding | 41.9 | |||||
| Days Payable | 17.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.1 | |||||
| Shareholder Yield % | 1.24 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -54.79 | |||||
| Operating Margin % | -91.42 | |||||
| Net Margin % | -88.69 | |||||
| FCF Margin % | -93.16 | |||||
| ROE % | -20.79 | |||||
| ROA % | -13.76 | |||||
| ROIC % | -17.99 | |||||
| ROC (Joel Greenblatt) % | -20.89 | |||||
| ROCE % | -15.38 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 18.68 | |||||
| PB Ratio | 4.82 | |||||
| Price-to-Tangible-Book | 4.91 | |||||
| EV-to-EBIT | -23.54 | |||||
| EV-to-EBITDA | -67.11 | |||||
| EV-to-Revenue | 19.43 | |||||
| EV-to-FCF | -21.36 | |||||
| Price-to-Median-PS-Value | 1.76 | |||||
| Earnings Yield (Greenblatt) % | -4.25 | |||||
| FCF Yield % | -4.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mycenax Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 576.984 | ||
| EPS (TTM) (NT$) | -2.48 | ||
| Beta | 0.87 | ||
| Volatility % | 38.4 | ||
| 14-Day RSI | 46.53 | ||
| 14-Day ATR (NT$) | 2.408346 | ||
| 20-Day SMA (NT$) | 52.09 | ||
| 12-1 Month Momentum % | 56.45 | ||
| 52-Week Range (NT$) | 33.85 - 65.2 | ||
| Shares Outstanding (Mil) | 206.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mycenax Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mycenax Biotech Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mycenax Biotech Inc Frequently Asked Questions
What is Mycenax Biotech Inc(ROCO:4726)'s stock price today?
The current price of ROCO:4726 is NT$52.20. The 52 week high of ROCO:4726 is NT$65.20 and 52 week low is NT$33.85.
When is next earnings date of Mycenax Biotech Inc(ROCO:4726)?
The next earnings date of Mycenax Biotech Inc(ROCO:4726) is .
Does Mycenax Biotech Inc(ROCO:4726) pay dividends? If so, how much?
Mycenax Biotech Inc(ROCO:4726) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers